COOPER COMPANIES, INC. cotiza a 54.59 USD y tiene una capitalización bursátil de $10.4B. En los últimos 12 meses ha facturado $4.2B con un margen de flujo de caja libre del 10.6%. Cotiza a 15.3 veces su flujo de caja libre (P/FCF) y a un PER de 18.2. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism…
| Periodo | 2026-12 | 2026-09 | 2026-06 | 2026-03 |
|---|---|---|---|---|
| Real | — | $1.15 | $1.21 | $1.10 |
| Estimado | $1.07 | $1.12 | $1.09 | $1.03 |
| Sorpresa | — | +2.7% | +11.0% | +6.8% |
| Métrica | COO | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 65.5% | 57.0% | +8.5% |
| Operating Margin | 16.7% | -38.6% | +55.3% |
| Net Margin | 9.2% | -33.6% | +42.7% |
| FCF Margin | 10.6% | -13.9% | +24.5% |
| ROE | 4.5% | -40.4% | +44.9% |
| ROA | 3.0% | -32.0% | +35.0% |
| Current Ratio | 1.89 | 2.84 | -0.95 |
| Debt / Equity | 0.30 | 0.28 | +0.02 |